久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Daiichi Sankyo Presents Positive Results from LIXIANA Study americanpharmaceuticalreview
    September 05, 2019
    Daiichi Sankyo announced results from ENTRUST-AF PCI, the first large randomized study to evaluate the efficacy and safety of once-daily edoxaban (known by the brand name LIXIANA?▼) plus a P2Y12 inhibitor...
PharmaSources Customer Service